CON

#1448
Concentra Group Holdings Parent, Inc. Common Stock
34.2 5 USD
-0.01%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
34.19
34.39
Jahresspanne
18.55
35.87
Tagesänderung
-1.30%
Monatliche Änderung
+7.17%
6 month change
+47.31%
Jahresänderung
+62.86%
Vorheriger Schlusskurs
34.7 0
Open
34.3 8
Tief
34.1 9
Hoch
34.3 9
Volumen
222
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, 21 Aug 2026
Concentra Group Holdings Parent, Inc. current report, 21 August 2026
8-K
Current report, Q3 FY2026
Concentra Group Holdings Parent, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Concentra Group Holdings Parent, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Concentra Group Holdings Parent, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Concentra Group Holdings Parent, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Concentra Group Holdings Parent, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Concentra Group Holdings Parent, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Concentra Group Holdings Parent, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Concentra Group Holdings Parent, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Concentra Group Holdings Parent, Inc. current report, Q1 FY2026
8-K

Concentra Group Holdings Parent, Inc. current report, Q2 FY2025

Full document

Concentra Group Holdings Parent, Inc. - 8-K Summary

Business Context and Reporting Period

This Form 8-K Current Report, dated May 1, 2025, details the results of the Annual Meeting of Stockholders held on that date. The filing covers the voting outcomes for four proposals submitted to shareholders.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a report on corporate governance voting results.

Material Changes and Voting Results

Stockholders approved all four proposals presented at the Annual Meeting:

  • Proposal 1 (Election of Directors): Two Class I directors were elected. Daniel J. Thomas received 112,356,457 votes for (vs. 5,387,232 against). Cheryl B. Pegus received 113,994,041 votes for (vs. 3,742,087 against).
  • Proposal 2 (Say-on-Pay): The non-binding advisory vote on executive compensation was approved with 92,051,122 votes for, compared to 25,350,156 votes against.
  • Proposal 3 (Frequency of Say-on-Pay): Shareholders voted to hold future advisory votes on compensation annually. The "1 Year" option received 113,659,054 votes, significantly outpacing the "3 Years" option (4,052,275 votes).
  • Proposal 4 (Auditor Ratification): The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified with 122,300,023 votes for and only 291,151 votes against.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of voting results.

Key Facts for Investor Verification

  • Verify the total number of shares outstanding to calculate the percentage of votes cast for each proposal.
  • Review the definitive proxy statement dated March 18, 2025, for detailed biographies of the elected directors and the specific compensation metrics voted upon.
  • Confirm the effective date of the auditor appointment for the 2025 fiscal year.